MyAverix Finance
F · Healthcare
Neurizon Therapeutics Limited (ECQ0)
Biotechnology
Neurizon Therapeutics Limited (ECQ0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $34.01M, P/E ratio is 18.00, net margin is -248.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ECQ0
Neurizon Therapeutics Limited (ECQ0) — FAQ
What is Neurizon Therapeutics Limited's market cap?
Neurizon Therapeutics Limited (ECQ0) has a reported market cap of $34.01M (data as of 2026-03-29).
What is ECQ0's P/E ratio?
The price-to-earnings (P/E) ratio for Neurizon Therapeutics Limited (ECQ0) is 18.00 (data as of 2026-03-29).
Does Neurizon Therapeutics Limited pay a dividend?
Dividend yield is not available in the current snapshot for Neurizon Therapeutics Limited (ECQ0). Check the MyAverix Finance app for the latest dividend data.
What sector is Neurizon Therapeutics Limited in?
Neurizon Therapeutics Limited (ECQ0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ECQ0 listed on?
ECQ0 is listed on F.
What is Neurizon Therapeutics Limited's net margin?
Neurizon Therapeutics Limited (ECQ0) reports a net margin of -248.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.